Cargando…
Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database
The known breast cancer susceptibility genes only account for 20% to 25% of the excess familial risk of the disease [1]. The present study assessed the contribution of BRCA1/2 mutations and CHEK2 variants to the relative risk of breast cancer for women with affected mothers or sisters. The familial...
Autores principales: | Bermejo, Justo Lorenzo, Pérez, Alfonso García, Hemminki, Kari |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840005/ https://www.ncbi.nlm.nih.gov/pubmed/20233462 http://dx.doi.org/10.1186/1897-4287-2-4-185 |
Ejemplares similares
-
The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence
por: Hemminki, Kari, et al.
Publicado: (2006) -
CHEK2 contribution to hereditary breast cancer in non-BRCA families
por: Desrichard, Alexis, et al.
Publicado: (2011) -
Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families
por: Cierniková, S, et al.
Publicado: (2005) -
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2
por: Kim, S, et al.
Publicado: (2008) -
BRCA2 gene mutations in families with aggregations of breast and stomach cancers
por: Jakubowska, A, et al.
Publicado: (2002)